Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00249574 · ClinicalTrials.gov registry record · NA

Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1

A NA study, sponsored by National Institute on Drug Abuse (NIDA).

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT00249574: Completed NA study, sponsored by National Institute on Drug Abuse (NIDA).

NCT00249574 is a NA study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00249574, a NA study, has completed, sponsored by National Institute on Drug Abuse (NIDA).

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The purpose of this study is to see whether street-recruited heroin users can be successfully treated for hepatitis C after stabilizing them on buprenorphine.

Interventions

  • DRUG Buprenorphine/naloxone
  • DRUG pegInterferon

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2003-06
Est. Completion 2006-06
Phase NA

What the finished NCT00249574 record still lists

NCT00249574 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Buprenorphine/naloxone is the first listed.

NCT00249574 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00249574 about?

NCT00249574 is a clinical study titled "Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1". The purpose of this study is to see whether street-recruited heroin users can be successfully treated for hepatitis C after stabilizing them on buprenorphine.

What is the current status of trial NCT00249574?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2003-06. Estimated completion is 2006-06.

What interventions are being tested in trial NCT00249574?

The interventions under investigation include: Buprenorphine/naloxone (DRUG), pegInterferon (DRUG).

Who is sponsoring clinical trial NCT00249574?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00249574's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00249574, the US trial registry maintained by the National Library of Medicine. NCT00249574 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.